Can Ultra-Low nicotine smokes help break the habit for those in pain?

NCT ID NCT06747871

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether switching to very low nicotine cigarettes can reduce cravings, withdrawal, and pain in people who smoke daily, have chronic pain, and are on buprenorphine for opioid use disorder. Sixty participants will be randomly assigned to either very low nicotine or normal nicotine cigarettes for several weeks. Researchers will measure changes in smoking behavior, pain levels, and withdrawal symptoms to see if this approach could support quitting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Very low nicotine cigarettes (VLNC) vs. normal nicotine cigarettes (NNC)

What this could lead to

If it works, this could point toward a safer way to help people with chronic pain and opioid use disorder reduce or quit smoking.

What could go wrong

This is a small, early-phase study (60 people) that only looks at short-term effects. It may not lead to a proven cessation method, and switching to very low nicotine cigarettes might not reduce cravings or pain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome nicotine dependence opiate dependence Tobacco Use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • North Pavilion

    RECRUITING

    Durham, North Carolina, 27705, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••